# Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

> **NCT00559286** · PHASE4 · TERMINATED · sponsor: **RWTH Aachen University** · enrollment: 40 (estimated)

## Conditions studied

- Arterial Hypertension
- Diabetes Mellitus Type 2 IRC or NIR

## Interventions

- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT00559286
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** logistic reasons, patients could not be recruited
- **Last updated:** 2009-01-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559286, "Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00559286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*